期刊文献+

基本药物可及性的规制机制分析 被引量:3

Analysis on regulation mechanism of accessibility to essential drugs
原文传递
导出
摘要 分析我国基本药物可及性规制中的经济性规制和社会性规制,发现单一的经济规制或社会规制不足以有效解决基本药物可及性中的问题,如经济性规制中的价格调控过程缺乏合适的补偿机制导致基本药物供需双向短缺,"统购统销"缺乏明确的规章制度导致效率问题的出现等;社会性规制中的基本药物制度的有关规定不够细化和明确及法律效力不够,缺乏引导服从的奖惩机制等。认为经济规制与社会规制应配合使用、协调进行,"药品降价"与"多渠道补偿"配合、"统购统销"与强制性的法律法规配套,通过经济规制为社会规制的展开准备良好的市场环境。 To analyze the economic regulation and social regulation in the regulation mechanism of the accessibility to the essential drugs and fred that it is not enough to solve the problems of the accessibility to essential drugs only by economic regulation or social regulation. For example, the lack of right compensatory mechanism during the price control in economic regulation could cause the bidirectional shortage of supply and demand for essential drugs and the lack of clear rules and regulations in "state monopoly over purchase and marketing" could bring the problem of inefficiency and so on. The law of essential drugs system in the social regulation is short of detailed and clear provisions, legal forces, and rewards and punishments system. Therefore, we consider that economic regulation and social regulation should be used in conjunction with coordinated, "drugs price reduction" should be in coordination with "multiple channel compensation", "state monopoly over purchase and marketing" should be in coordination with strict rules and regulations, and economic regulation could provide a nice market circumstances for social regulation.
出处 《现代药物与临床》 CAS 2011年第5期415-420,共6页 Drugs & Clinic
关键词 基本药物 可及性 经济性规制 社会性规制 药品政策 essential drugs accessibility economic regulation social regulation drug policy
  • 相关文献

参考文献9

二级参考文献25

  • 1郑立华.美国制药业背后的疯狂[J].中国医药导报,2006,3(19):64-65. 被引量:1
  • 2边博洋,邵蓉.美国当代药品流通体系研究[J].上海医药,2007,28(5):205-207. 被引量:1
  • 3[美] 雷克斯福特·E·桑特勒.《卫生经济学-理论、案例和产业研究》[M] 第3版,北京:北京大学出版社,2006.5-6.
  • 4植草益.《微观规制经济学》中文版[M].北京:中国发展出版社,1992.228,228,233-236页.
  • 5丹尼尔·F.史普博.《管制与市场》,中文版,上海,上海三联书店,1999.
  • 6约翰·内维尔·凯恩斯.《政治经济学的范围与方法》,中文版,北京,华夏出版社,2001.
  • 7张培刚.《农业和工业化》(上卷),武汉,华中工学院出版社,1984.
  • 8Kahn, A. E., 1970. The Economics of Regulation: Principles and Institutions. New York: Wiley.
  • 9Viscusi, W. Kip, 1984. Regulating Consumer Product Safety :American Enterprise Institute for Public Policy Reseach Washington and London. p.42.
  • 10Macavoy, Patti W., 1992.Industry Regulation and the Performance of the American Economy.New york: W.W. Norton & Company, Inc..

共引文献274

同被引文献21

  • 1杨莉.基本药物生产存在问题分析和政策建议[J].中国卫生政策研究,2009,2(1):43-46. 被引量:4
  • 2刘宝,武瑞雪,叶露.论基本药物的可获得性和可及性障碍[J].中国药房,2007,18(14):1041-1043. 被引量:45
  • 3Bettina Lange, Andy Gouldson. Trust-based environmental regulation[J]. Science of the total environment, 2010, 408(22):5235-5243.
  • 4John Braithwaite. Responsive regulation and developing economies[J]. World development, 2006, 34(5):884-898.
  • 5Peter Van Gossum, Bas Arts, Kris Verheyen. "Smart regulation" : Can policy instrument design solve forest policy aims of expansion and sustainability in Flanders and the Netherlands?[J]. Forest policy and economics, 2012,(16):23-24.
  • 6中国药材网.中药材价格数据库[DB/OL].(2012.11.02)[2013-01-05].http://www.zyctd.com/exchange-prices-486-1-0.html.
  • 7中国青年报.廉价药看得见吃不着专家不看好基药统一定价[EB/OL].(2011-10-24)[2013-01-05].http://www.menet.con.cn/Articles/Economy/201110/20111024085742574256751.html.
  • 8第一财经日报.基药制度前景未明,药企利润增幅减速恐成定局[EB/OL].(2011-08-15)[2013-01-05].http://news.xinhuanet.corrr/health/2011-08/15/e-121859660.htm.
  • 9经济观察报.卫生部酝酿基本药物目录调整常规用药将大提取[EB/OL].[2013-01-05].http://news.hxyjw.com/yigai/1381947.
  • 10叶露,陈文,应晓华,刘宝,胡善联.我国基本药物生产流通使用中存在问题和成因分析[J].中国卫生资源,2008,11(2):51-53. 被引量:35

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部